Purification, structural characteristics and anti-atherosclerosis activity of a novel green tea polysaccharide

Int J Biol Macromol. 2024 Jan;254(Pt 1):127705. doi: 10.1016/j.ijbiomac.2023.127705. Epub 2023 Oct 31.

Abstract

A new homogeneous polysaccharide (TPS3A) was isolated and purified from Tianzhu Xianyue fried green tea by DEAE-52 cellulose and Sephacryl S-500 column chromatography. Structural characterization indicated that TPS3A mainly consisted of arabinose, galactose, galacturonic acid and rhamnose in a molar ratio of 5.84: 4.15: 2.06: 1, with an average molecular weight of 1.596 × 104 kDa. The structure of TPS3A was characterized as a repeating unit consisting of 1,3-Galp, 1,4-Galp, 1,3,6-Galp, 1,3-Araf, 1,5-Araf, 1,2,4-Rhap and 1-GalpA, with two branches on the C6 of 1,3,6-Galp and C2 of 1,2,4-Rhap, respectively. To investigate the preventive effects of TPS3A on atherosclerosis, TPS3A was administered orally to ApoE-deficient (ApoE-/-) mice. Results revealed that TPS3A intervention could effectively delay the atherosclerotic plaque progression, modulate dyslipidemia, and reduce the transformation of vascular smooth muscle cells (VSMCs) from contractile phenotype to synthetic phenotype by activating the expression of contractile marker alpha-smooth muscle actin (α-SMA) and inhibiting the expression of synthetic marker osteopontin (OPN) in high-fat diet-induced ApoE-/- mice. Our findings suggested that TPS3A markedly alleviated atherosclerosis by regulating dyslipidemia and phenotypic transition of VSMCs, and might be used as a novel functional ingredient to promote cardiovascular health.

Keywords: Anti-atherosclerosis; Chemical structure; Green tea; Polysaccharide.

MeSH terms

  • Animals
  • Apolipoproteins E
  • Atherosclerosis* / drug therapy
  • Dyslipidemias*
  • Mice
  • Polysaccharides / analysis
  • Polysaccharides / pharmacology
  • Polysaccharides / therapeutic use
  • Tea

Substances

  • Tea
  • Polysaccharides
  • Apolipoproteins E